In the current work, we explored the mechanism by which ADAM8 modulates intracellular and extracellular signaling through the regulation of miR-181a-5p expression and uncovered MMP9 as a miR-181a-5p dependent target gene in GBM. The gene discussed is MMP9; the disease is glioblastoma.